维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="WEIKERT C"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Gamma-glutamyltrans- ferase, cardiovascular disease and mortality in individuals withdiabetes mellitus 显示文摘	Sluik D Beulens JW Weikert C	2012	Diabetes Metab Res Rev2012，28，3：	1
2	Effects of endotoxin and catecholamines on hepatic mitochondrial respiration显示文摘	Porta F Bracht H Weikert C		0，，：	1
3	Efficacy of sunitinib re- exposure after failure of an roTOR inhibitor in patients with meta- static RCC显示文摘	Grunwald V Weikert S Seidel C	2011	Onkologie2011，34，6：	1
4	Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications 显示文摘	Christoph F Weikert S Kempkensteffen C	2006	Clin Cancer Res2006，12，17：	1
5	Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors显示文摘	Weikert S Kempkensteffen C Busch J	2013	World journal of urology2013，，31：	1
6	Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer 显示文摘	Christoph F Kempkensteffen C Weikert S	2006	Br J Cancer2006，95，12：	1
7	Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer显示文摘	Christoph F Kempkensteffen C Weikert S	2006	Br J Cancer2006，95，12：	1
8	Gamma-glutamyhransferase, cardiovascular disease and mortality in individuals with diabetes melli- tus显示文摘	Sluik D Beulens J W Weikert C	2012	Diabetes Metab Res Rev2012，28，3：	1
9	Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma显示文摘	Busch J Seidel C Weikert S	2011	Buschet al BMC Cancer2011，，11：	1
10	R- egularly methylated novel proapoptotic genes associated with recurrence in transitional cell carcinoma of the bladder显示文摘	CHRISTOPH F WEIKERT S KEMPKENSTEFFEN C	2006	Int J Cancer2006，119，6：	1
11	Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer显示文摘	Christoph F Kempkensteffen C Weikert S	2006	Br J Cancer2006，95，12：	1
12	Adverse events associated with tes- tosterone administration 显示文摘	Weikert C Pischon T Weikert S	2010	N Engl J Med2010，363，19：	1
13	Intake of vegetables,legume,and fruit,and risk for all-cause,cardiovascular,and cancer mortali-ty in a European diabetic population显示文摘	NOTHLINGS U SCHULZE M B WEIKERT C	2008	J Nutr2008，138，：	1
14	Association of seep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC) - Potsdam study 显示文摘	VON RUESTEN A WEIKERT C FIETZE I	2012	PLoSOne2012，7，30：	1
15	EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder显示文摘	Hinz S Kempkensteffen C Weikert S	2007	Tumour Biol2007，28，3：	1
16	Plasma fetuin a levels and the risk of type 2 diabetes显示文摘	Stefan N Fritsche A Weikert C	2008	Diabetes2008，57，：	1
17	Plasma resistin levels and risk of myocardial infarction and ischemic stroke显示文摘	Weikert C Westphal S Berger K	2008	J Clin Endocrinol Metab2008，93，7：	1
18	Plasmafetuin-A levels and the risk of type 2 diabetes显示文摘	Stefan N Fritsche A Weikert C	2008	Diabetes2008，57，10：	1
19	Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma显示文摘	Seidel C Busch J Weikert S	2012	Eur J Cancer2012，48，：	1
20	Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke显示文摘	Weikert C Stefan N Schulze MB	2008	Circulation2008，118，24：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示